In addition, ATF3 can improve hepatic macrophage glucolipid metabolism and reduce hepatocyte steatosis depending on retinol-binding protein 4 (RBP4) in the pathogenesis of MASH (179). This evidence concerns the gene RBP4 and metabolic dysfunction-associated steatohepatitis.